Reports

Industry Research Reports

Global Cell therapy Processing Market Research Report 2024

Global Cell therapy Processing Market Research Report 2024

Industry: Machinery & Equipment

Published Date: 2024-01-11

Pages: 101 Pages

Report ld: 2189858

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

The global Cell therapy Processing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Cell therapy Processing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Cell therapy Processing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Cell therapy Processing in Cardiovascular Disease is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Cell therapy Processing include Anthrogenesis Corp., BioNTech, Cell Ideas, Epic Sciences, Roche, FuGENE, IBC Pharmaceuticals Inc., Bluebird Bio Inc. and Immodulon-Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Cell therapy Processing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell therapy Processing.

MARKET SEGMENTATION

By Company

  • Anthrogenesis Corp.
  • BioNTech
  • Cell Ideas
  • Epic Sciences
  • Roche
  • FuGENE
  • IBC Pharmaceuticals Inc.
  • Bluebird Bio Inc.
  • Immodulon-Therapeutics
  • Immunomedics Inc.
  • Juno Therapeutics Inc.
  • Medlmmune Inc.
  • NeoStem Oncology
  • Neurotech USA
  • Novartis
  • Persimmune Inc.
  • Pluristem Therapeutics
  • BioMed Valley Discoveries Inc.
  • Regeneron Pharmaceuticals Inc.
  • UCL Business PLC.

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Products
  • Services
  • Software

Segment by Application

  • Cardiovascular Disease
  • Bone Repair
  • Neurological Disorders
  • Skeletal Muscle RepairImmune Diseases

biaoTi REPORT SCOPE

The Cell therapy Processing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cell therapy Processing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cell therapy Processing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

marn_i1

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

marn_i1

Chapter 3: Detailed analysis of Cell therapy Processing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

marn_i1

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

marn_i1

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

marn_i1

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

marn_i1

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

marn_i1

Chapter 12: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cell therapy Processing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Products

1.2.3 Services

1.2.4 Software

1.3 Market by Application

1.3.1 Global Cell therapy Processing Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Cardiovascular Disease

1.3.3 Bone Repair

1.3.4 Neurological Disorders

1.3.5 Skeletal Muscle RepairImmune Diseases

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

muLu

2 Global Growth Trends

2.1 Global Cell therapy Processing Market Perspective (2019-2030)

2.2 Cell therapy Processing Growth Trends by Region

2.2.1 Global Cell therapy Processing Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Cell therapy Processing Historic Market Size by Region (2019-2024)

2.2.3 Cell therapy Processing Forecasted Market Size by Region (2025-2030)

2.3 Cell therapy Processing Market Dynamics

2.3.1 Cell therapy Processing Industry Trends

2.3.2 Cell therapy Processing Market Drivers

2.3.3 Cell therapy Processing Market Challenges

2.3.4 Cell therapy Processing Market Restraints

muLu

3 Competition Landscape by Key Players

3.1 Global Top Cell therapy Processing Players by Revenue

3.1.1 Global Top Cell therapy Processing Players by Revenue (2019-2024)

3.1.2 Global Cell therapy Processing Revenue Market Share by Players (2019-2024)

3.2 Global Cell therapy Processing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Cell therapy Processing Revenue

3.4 Global Cell therapy Processing Market Concentration Ratio

3.4.1 Global Cell therapy Processing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cell therapy Processing Revenue in 2023

3.5 Cell therapy Processing Key Players Head office and Area Served

3.6 Key Players Cell therapy Processing Product Solution and Service

3.7 Date of Enter into Cell therapy Processing Market

3.8 Mergers & Acquisitions, Expansion Plans

muLu

4 Cell therapy Processing Breakdown Data by Type

4.1 Global Cell therapy Processing Historic Market Size by Type (2019-2024)

4.2 Global Cell therapy Processing Forecasted Market Size by Type (2025-2030)

muLu

5 Cell therapy Processing Breakdown Data by Application

5.1 Global Cell therapy Processing Historic Market Size by Application (2019-2024)

5.2 Global Cell therapy Processing Forecasted Market Size by Application (2025-2030)

muLu

6 North America

6.1 North America Cell therapy Processing Market Size (2019-2030)

6.2 North America Cell therapy Processing Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Cell therapy Processing Market Size by Country (2019-2024)

6.4 North America Cell therapy Processing Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

muLu

7 Europe

7.1 Europe Cell therapy Processing Market Size (2019-2030)

7.2 Europe Cell therapy Processing Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Cell therapy Processing Market Size by Country (2019-2024)

7.4 Europe Cell therapy Processing Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

muLu

8 Asia-Pacific

8.1 Asia-Pacific Cell therapy Processing Market Size (2019-2030)

8.2 Asia-Pacific Cell therapy Processing Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Cell therapy Processing Market Size by Region (2019-2024)

8.4 Asia-Pacific Cell therapy Processing Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

muLu

9 Latin America

9.1 Latin America Cell therapy Processing Market Size (2019-2030)

9.2 Latin America Cell therapy Processing Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Cell therapy Processing Market Size by Country (2019-2024)

9.4 Latin America Cell therapy Processing Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

muLu

10 Middle East & Africa

10.1 Middle East & Africa Cell therapy Processing Market Size (2019-2030)

10.2 Middle East & Africa Cell therapy Processing Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Cell therapy Processing Market Size by Country (2019-2024)

10.4 Middle East & Africa Cell therapy Processing Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

muLu

11 Key Players Profiles

11.1 Anthrogenesis Corp.

11.1.1 Anthrogenesis Corp. Company Detail

11.1.2 Anthrogenesis Corp. Business Overview

11.1.3 Anthrogenesis Corp. Cell therapy Processing Introduction

11.1.4 Anthrogenesis Corp. Revenue in Cell therapy Processing Business (2019-2024)

11.1.5 Anthrogenesis Corp. Recent Development

11.2 BioNTech

11.2.1 BioNTech Company Detail

11.2.2 BioNTech Business Overview

11.2.3 BioNTech Cell therapy Processing Introduction

11.2.4 BioNTech Revenue in Cell therapy Processing Business (2019-2024)

11.2.5 BioNTech Recent Development

11.3 Cell Ideas

11.3.1 Cell Ideas Company Detail

11.3.2 Cell Ideas Business Overview

11.3.3 Cell Ideas Cell therapy Processing Introduction

11.3.4 Cell Ideas Revenue in Cell therapy Processing Business (2019-2024)

11.3.5 Cell Ideas Recent Development

11.4 Epic Sciences

11.4.1 Epic Sciences Company Detail

11.4.2 Epic Sciences Business Overview

11.4.3 Epic Sciences Cell therapy Processing Introduction

11.4.4 Epic Sciences Revenue in Cell therapy Processing Business (2019-2024)

11.4.5 Epic Sciences Recent Development

11.5 Roche

11.5.1 Roche Company Detail

11.5.2 Roche Business Overview

11.5.3 Roche Cell therapy Processing Introduction

11.5.4 Roche Revenue in Cell therapy Processing Business (2019-2024)

11.5.5 Roche Recent Development

11.6 FuGENE

11.6.1 FuGENE Company Detail

11.6.2 FuGENE Business Overview

11.6.3 FuGENE Cell therapy Processing Introduction

11.6.4 FuGENE Revenue in Cell therapy Processing Business (2019-2024)

11.6.5 FuGENE Recent Development

11.7 IBC Pharmaceuticals Inc.

11.7.1 IBC Pharmaceuticals Inc. Company Detail

11.7.2 IBC Pharmaceuticals Inc. Business Overview

11.7.3 IBC Pharmaceuticals Inc. Cell therapy Processing Introduction

11.7.4 IBC Pharmaceuticals Inc. Revenue in Cell therapy Processing Business (2019-2024)

11.7.5 IBC Pharmaceuticals Inc. Recent Development

11.8 Bluebird Bio Inc.

11.8.1 Bluebird Bio Inc. Company Detail

11.8.2 Bluebird Bio Inc. Business Overview

11.8.3 Bluebird Bio Inc. Cell therapy Processing Introduction

11.8.4 Bluebird Bio Inc. Revenue in Cell therapy Processing Business (2019-2024)

11.8.5 Bluebird Bio Inc. Recent Development

11.9 Immodulon-Therapeutics

11.9.1 Immodulon-Therapeutics Company Detail

11.9.2 Immodulon-Therapeutics Business Overview

11.9.3 Immodulon-Therapeutics Cell therapy Processing Introduction

11.9.4 Immodulon-Therapeutics Revenue in Cell therapy Processing Business (2019-2024)

11.9.5 Immodulon-Therapeutics Recent Development

11.10 Immunomedics Inc.

11.10.1 Immunomedics Inc. Company Detail

11.10.2 Immunomedics Inc. Business Overview

11.10.3 Immunomedics Inc. Cell therapy Processing Introduction

11.10.4 Immunomedics Inc. Revenue in Cell therapy Processing Business (2019-2024)

11.10.5 Immunomedics Inc. Recent Development

11.11 Juno Therapeutics Inc.

11.11.1 Juno Therapeutics Inc. Company Detail

11.11.2 Juno Therapeutics Inc. Business Overview

11.11.3 Juno Therapeutics Inc. Cell therapy Processing Introduction

11.11.4 Juno Therapeutics Inc. Revenue in Cell therapy Processing Business (2019-2024)

11.11.5 Juno Therapeutics Inc. Recent Development

11.12 Medlmmune Inc.

11.12.1 Medlmmune Inc. Company Detail

11.12.2 Medlmmune Inc. Business Overview

11.12.3 Medlmmune Inc. Cell therapy Processing Introduction

11.12.4 Medlmmune Inc. Revenue in Cell therapy Processing Business (2019-2024)

11.12.5 Medlmmune Inc. Recent Development

11.13 NeoStem Oncology

11.13.1 NeoStem Oncology Company Detail

11.13.2 NeoStem Oncology Business Overview

11.13.3 NeoStem Oncology Cell therapy Processing Introduction

11.13.4 NeoStem Oncology Revenue in Cell therapy Processing Business (2019-2024)

11.13.5 NeoStem Oncology Recent Development

11.14 Neurotech USA

11.14.1 Neurotech USA Company Detail

11.14.2 Neurotech USA Business Overview

11.14.3 Neurotech USA Cell therapy Processing Introduction

11.14.4 Neurotech USA Revenue in Cell therapy Processing Business (2019-2024)

11.14.5 Neurotech USA Recent Development

11.15 Novartis

11.15.1 Novartis Company Detail

11.15.2 Novartis Business Overview

11.15.3 Novartis Cell therapy Processing Introduction

11.15.4 Novartis Revenue in Cell therapy Processing Business (2019-2024)

11.15.5 Novartis Recent Development

11.16 Persimmune Inc.

11.16.1 Persimmune Inc. Company Detail

11.16.2 Persimmune Inc. Business Overview

11.16.3 Persimmune Inc. Cell therapy Processing Introduction

11.16.4 Persimmune Inc. Revenue in Cell therapy Processing Business (2019-2024)

11.16.5 Persimmune Inc. Recent Development

11.17 Pluristem Therapeutics

11.17.1 Pluristem Therapeutics Company Detail

11.17.2 Pluristem Therapeutics Business Overview

11.17.3 Pluristem Therapeutics Cell therapy Processing Introduction

11.17.4 Pluristem Therapeutics Revenue in Cell therapy Processing Business (2019-2024)

11.17.5 Pluristem Therapeutics Recent Development

11.18 BioMed Valley Discoveries Inc.

11.18.1 BioMed Valley Discoveries Inc. Company Detail

11.18.2 BioMed Valley Discoveries Inc. Business Overview

11.18.3 BioMed Valley Discoveries Inc. Cell therapy Processing Introduction

11.18.4 BioMed Valley Discoveries Inc. Revenue in Cell therapy Processing Business (2019-2024)

11.18.5 BioMed Valley Discoveries Inc. Recent Development

11.19 Regeneron Pharmaceuticals Inc.

11.19.1 Regeneron Pharmaceuticals Inc. Company Detail

11.19.2 Regeneron Pharmaceuticals Inc. Business Overview

11.19.3 Regeneron Pharmaceuticals Inc. Cell therapy Processing Introduction

11.19.4 Regeneron Pharmaceuticals Inc. Revenue in Cell therapy Processing Business (2019-2024)

11.19.5 Regeneron Pharmaceuticals Inc. Recent Development

11.20 UCL Business PLC.

11.20.1 UCL Business PLC. Company Detail

11.20.2 UCL Business PLC. Business Overview

11.20.3 UCL Business PLC. Cell therapy Processing Introduction

11.20.4 UCL Business PLC. Revenue in Cell therapy Processing Business (2019-2024)

11.20.5 UCL Business PLC. Recent Development

muLu

12 Analyst's Viewpoints/Conclusions

muLu

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Cell therapy Processing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Products
Table 3. Key Players of Services
Table 4. Key Players of Software
Table 5. Global Cell therapy Processing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Cell therapy Processing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Cell therapy Processing Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Cell therapy Processing Market Share by Region (2019-2024)
Table 9. Global Cell therapy Processing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Cell therapy Processing Market Share by Region (2025-2030)
Table 11. Cell therapy Processing Market Trends
Table 12. Cell therapy Processing Market Drivers
Table 13. Cell therapy Processing Market Challenges
Table 14. Cell therapy Processing Market Restraints
Table 15. Global Cell therapy Processing Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Cell therapy Processing Market Share by Players (2019-2024)
Table 17. Global Top Cell therapy Processing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell therapy Processing as of 2023)
Table 18. Ranking of Global Top Cell therapy Processing Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Cell therapy Processing Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cell therapy Processing Product Solution and Service
Table 22. Date of Enter into Cell therapy Processing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cell therapy Processing Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Cell therapy Processing Revenue Market Share by Type (2019-2024)
Table 26. Global Cell therapy Processing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Cell therapy Processing Revenue Market Share by Type (2025-2030)
Table 28. Global Cell therapy Processing Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Cell therapy Processing Revenue Market Share by Application (2019-2024)
Table 30. Global Cell therapy Processing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Cell therapy Processing Revenue Market Share by Application (2025-2030)
Table 32. North America Cell therapy Processing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Cell therapy Processing Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Cell therapy Processing Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Cell therapy Processing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Cell therapy Processing Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Cell therapy Processing Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Cell therapy Processing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Cell therapy Processing Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Cell therapy Processing Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Cell therapy Processing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Cell therapy Processing Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Cell therapy Processing Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Cell therapy Processing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Cell therapy Processing Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Cell therapy Processing Market Size by Country (2025-2030) & (US$ Million)
Table 47. Anthrogenesis Corp. Company Detail
Table 48. Anthrogenesis Corp. Business Overview
Table 49. Anthrogenesis Corp. Cell therapy Processing Product
Table 50. Anthrogenesis Corp. Revenue in Cell therapy Processing Business (2019-2024) & (US$ Million)
Table 51. Anthrogenesis Corp. Recent Development
Table 52. BioNTech Company Detail
Table 53. BioNTech Business Overview
Table 54. BioNTech Cell therapy Processing Product
Table 55. BioNTech Revenue in Cell therapy Processing Business (2019-2024) & (US$ Million)
Table 56. BioNTech Recent Development
Table 57. Cell Ideas Company Detail
Table 58. Cell Ideas Business Overview
Table 59. Cell Ideas Cell therapy Processing Product
Table 60. Cell Ideas Revenue in Cell therapy Processing Business (2019-2024) & (US$ Million)
Table 61. Cell Ideas Recent Development
Table 62. Epic Sciences Company Detail
Table 63. Epic Sciences Business Overview
Table 64. Epic Sciences Cell therapy Processing Product
Table 65. Epic Sciences Revenue in Cell therapy Processing Business (2019-2024) & (US$ Million)
Table 66. Epic Sciences Recent Development
Table 67. Roche Company Detail
Table 68. Roche Business Overview
Table 69. Roche Cell therapy Processing Product
Table 70. Roche Revenue in Cell therapy Processing Business (2019-2024) & (US$ Million)
Table 71. Roche Recent Development
Table 72. FuGENE Company Detail
Table 73. FuGENE Business Overview
Table 74. FuGENE Cell therapy Processing Product
Table 75. FuGENE Revenue in Cell therapy Processing Business (2019-2024) & (US$ Million)
Table 76. FuGENE Recent Development
Table 77. IBC Pharmaceuticals Inc. Company Detail
Table 78. IBC Pharmaceuticals Inc. Business Overview
Table 79. IBC Pharmaceuticals Inc. Cell therapy Processing Product
Table 80. IBC Pharmaceuticals Inc. Revenue in Cell therapy Processing Business (2019-2024) & (US$ Million)
Table 81. IBC Pharmaceuticals Inc. Recent Development
Table 82. Bluebird Bio Inc. Company Detail
Table 83. Bluebird Bio Inc. Business Overview
Table 84. Bluebird Bio Inc. Cell therapy Processing Product
Table 85. Bluebird Bio Inc. Revenue in Cell therapy Processing Business (2019-2024) & (US$ Million)
Table 86. Bluebird Bio Inc. Recent Development
Table 87. Immodulon-Therapeutics Company Detail
Table 88. Immodulon-Therapeutics Business Overview
Table 89. Immodulon-Therapeutics Cell therapy Processing Product
Table 90. Immodulon-Therapeutics Revenue in Cell therapy Processing Business (2019-2024) & (US$ Million)
Table 91. Immodulon-Therapeutics Recent Development
Table 92. Immunomedics Inc. Company Detail
Table 93. Immunomedics Inc. Business Overview
Table 94. Immunomedics Inc. Cell therapy Processing Product
Table 95. Immunomedics Inc. Revenue in Cell therapy Processing Business (2019-2024) & (US$ Million)
Table 96. Immunomedics Inc. Recent Development
Table 97. Juno Therapeutics Inc. Company Detail
Table 98. Juno Therapeutics Inc. Business Overview
Table 99. Juno Therapeutics Inc. Cell therapy Processing Product
Table 100. Juno Therapeutics Inc. Revenue in Cell therapy Processing Business (2019-2024) & (US$ Million)
Table 101. Juno Therapeutics Inc. Recent Development
Table 102. Medlmmune Inc. Company Detail
Table 103. Medlmmune Inc. Business Overview
Table 104. Medlmmune Inc. Cell therapy Processing Product
Table 105. Medlmmune Inc. Revenue in Cell therapy Processing Business (2019-2024) & (US$ Million)
Table 106. Medlmmune Inc. Recent Development
Table 107. NeoStem Oncology Company Detail
Table 108. NeoStem Oncology Business Overview
Table 109. NeoStem Oncology Cell therapy Processing Product
Table 110. NeoStem Oncology Revenue in Cell therapy Processing Business (2019-2024) & (US$ Million)
Table 111. NeoStem Oncology Recent Development
Table 112. Neurotech USA Company Detail
Table 113. Neurotech USA Business Overview
Table 114. Neurotech USA Cell therapy Processing Product
Table 115. Neurotech USA Revenue in Cell therapy Processing Business (2019-2024) & (US$ Million)
Table 116. Neurotech USA Recent Development
Table 117. Novartis Company Detail
Table 118. Novartis Business Overview
Table 119. Novartis Cell therapy Processing Product
Table 120. Novartis Revenue in Cell therapy Processing Business (2019-2024) & (US$ Million)
Table 121. Novartis Recent Development
Table 122. Persimmune Inc. Company Detail
Table 123. Persimmune Inc. Business Overview
Table 124. Persimmune Inc. Cell therapy Processing Product
Table 125. Persimmune Inc. Revenue in Cell therapy Processing Business (2019-2024) & (US$ Million)
Table 126. Persimmune Inc. Recent Development
Table 127. Pluristem Therapeutics Company Detail
Table 128. Pluristem Therapeutics Business Overview
Table 129. Pluristem Therapeutics Cell therapy Processing Product
Table 130. Pluristem Therapeutics Revenue in Cell therapy Processing Business (2019-2024) & (US$ Million)
Table 131. Pluristem Therapeutics Recent Development
Table 132. BioMed Valley Discoveries Inc. Company Detail
Table 133. BioMed Valley Discoveries Inc. Business Overview
Table 134. BioMed Valley Discoveries Inc. Cell therapy Processing Product
Table 135. BioMed Valley Discoveries Inc. Revenue in Cell therapy Processing Business (2019-2024) & (US$ Million)
Table 136. BioMed Valley Discoveries Inc. Recent Development
Table 137. Regeneron Pharmaceuticals Inc. Company Detail
Table 138. Regeneron Pharmaceuticals Inc. Business Overview
Table 139. Regeneron Pharmaceuticals Inc. Cell therapy Processing Product
Table 140. Regeneron Pharmaceuticals Inc. Revenue in Cell therapy Processing Business (2019-2024) & (US$ Million)
Table 141. Regeneron Pharmaceuticals Inc. Recent Development
Table 142. UCL Business PLC. Company Detail
Table 143. UCL Business PLC. Business Overview
Table 144. UCL Business PLC. Cell therapy Processing Product
Table 145. UCL Business PLC. Revenue in Cell therapy Processing Business (2019-2024) & (US$ Million)
Table 146. UCL Business PLC. Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Global Cell therapy Processing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Cell therapy Processing Market Share by Type: 2023 VS 2030
Figure 3. Products Features
Figure 4. Services Features
Figure 5. Software Features
Figure 6. Global Cell therapy Processing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Cell therapy Processing Market Share by Application: 2023 VS 2030
Figure 8. Cardiovascular Disease Case Studies
Figure 9. Bone Repair Case Studies
Figure 10. Neurological Disorders Case Studies
Figure 11. Skeletal Muscle RepairImmune Diseases Case Studies
Figure 12. Cell therapy Processing Report Years Considered
Figure 13. Global Cell therapy Processing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Cell therapy Processing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Cell therapy Processing Market Share by Region: 2023 VS 2030
Figure 16. Global Cell therapy Processing Market Share by Players in 2023
Figure 17. Global Top Cell therapy Processing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell therapy Processing as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Cell therapy Processing Revenue in 2023
Figure 19. North America Cell therapy Processing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Cell therapy Processing Market Share by Country (2019-2030)
Figure 21. United States Cell therapy Processing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Cell therapy Processing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Cell therapy Processing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Cell therapy Processing Market Share by Country (2019-2030)
Figure 25. Germany Cell therapy Processing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Cell therapy Processing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Cell therapy Processing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Cell therapy Processing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Cell therapy Processing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Cell therapy Processing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Cell therapy Processing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Cell therapy Processing Market Share by Region (2019-2030)
Figure 33. China Cell therapy Processing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Cell therapy Processing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Cell therapy Processing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Cell therapy Processing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Cell therapy Processing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Cell therapy Processing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Cell therapy Processing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Cell therapy Processing Market Share by Country (2019-2030)
Figure 41. Mexico Cell therapy Processing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Cell therapy Processing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Cell therapy Processing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Cell therapy Processing Market Share by Country (2019-2030)
Figure 45. Turkey Cell therapy Processing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Cell therapy Processing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Anthrogenesis Corp. Revenue Growth Rate in Cell therapy Processing Business (2019-2024)
Figure 48. BioNTech Revenue Growth Rate in Cell therapy Processing Business (2019-2024)
Figure 49. Cell Ideas Revenue Growth Rate in Cell therapy Processing Business (2019-2024)
Figure 50. Epic Sciences Revenue Growth Rate in Cell therapy Processing Business (2019-2024)
Figure 51. Roche Revenue Growth Rate in Cell therapy Processing Business (2019-2024)
Figure 52. FuGENE Revenue Growth Rate in Cell therapy Processing Business (2019-2024)
Figure 53. IBC Pharmaceuticals Inc. Revenue Growth Rate in Cell therapy Processing Business (2019-2024)
Figure 54. Bluebird Bio Inc. Revenue Growth Rate in Cell therapy Processing Business (2019-2024)
Figure 55. Immodulon-Therapeutics Revenue Growth Rate in Cell therapy Processing Business (2019-2024)
Figure 56. Immunomedics Inc. Revenue Growth Rate in Cell therapy Processing Business (2019-2024)
Figure 57. Juno Therapeutics Inc. Revenue Growth Rate in Cell therapy Processing Business (2019-2024)
Figure 58. Medlmmune Inc. Revenue Growth Rate in Cell therapy Processing Business (2019-2024)
Figure 59. NeoStem Oncology Revenue Growth Rate in Cell therapy Processing Business (2019-2024)
Figure 60. Neurotech USA Revenue Growth Rate in Cell therapy Processing Business (2019-2024)
Figure 61. Novartis Revenue Growth Rate in Cell therapy Processing Business (2019-2024)
Figure 62. Persimmune Inc. Revenue Growth Rate in Cell therapy Processing Business (2019-2024)
Figure 63. Pluristem Therapeutics Revenue Growth Rate in Cell therapy Processing Business (2019-2024)
Figure 64. BioMed Valley Discoveries Inc. Revenue Growth Rate in Cell therapy Processing Business (2019-2024)
Figure 65. Regeneron Pharmaceuticals Inc. Revenue Growth Rate in Cell therapy Processing Business (2019-2024)
Figure 66. UCL Business PLC. Revenue Growth Rate in Cell therapy Processing Business (2019-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Cell therapy Processing market?zhanKai
The top companies in the global Cell therapy Processing market are Anthrogenesis Corp.、BioNTech、Cell Ideas.
den_biaoTiZhungShi

Related Reports

Global Cell therapy Processing Market Research Report 2024

Industry: Machinery & Equipment

Published Date: 2024-01-11

Pages: 101 Pages

Report ld: 2189858

CHOOSE LICENSE TYPE
tip

USD 2900.00

tip

USD 4350.00

tip

USD 5800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Online

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

REPORT SCOPE

den_ic7

CHAPTER OUTLINE

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now